Lataa...
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab
Weight loss and muscle wasting are of critical importance to cancer patients because of their negative effects on survival, functional status, and tolerability of chemotherapy. Because previous data suggest vascular endothelial growth factor receptor inhibitors disrupt skeletal muscle pathways, such...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3166554/ https://ncbi.nlm.nih.gov/pubmed/21399996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-011-9894-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|